Dual therapy with high-dose of rabeprazole and amoxicilline versus triple therapy with rabeprazole, amoxicilline and metronidazole as the second line therapy for the cure of H-pylori infection.

被引：0
|
作者：
Shirai, N
Furuta, T
Sugimoto, M
Nakamura, A
Kajimura, M
Takeshita, A
Maekawa, M
Ohashi, K
Ishizaki, T
Hishida, A
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A430 / A430
页数：1
相关论文
共 50 条
  • [41] High-dose Dual Therapy Is Superior to Standard First-line or Rescue Therapy for Helicobacter pylori Infection
    Yang, Jyh-Chin
    Lin, Chun-Jung
    Wang, Hong-Long
    Chen, Jin-De
    Kao, John Y.
    Shun, Chia-Tung
    Lu, Chien-Wei
    Lin, Bor-Ru
    Shieh, Ming-Jium
    Chang, Ming-Chu
    Chang, Yu-Ting
    Wei, Shu-Chen
    Lin, Lin-Chih
    Yeh, Wen-Chun
    Kuo, Jen-Shin
    Tung, Chien-Chih
    Leong, Yew-Loong
    Wang, Teh-Hong
    Wong, Jau-Min
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (05) : 895 - U574
  • [42] Sequential Therapy Versus Standard Triple Therapies for H-pylori Infection in Children
    Bontems, P.
    Kalach, N.
    Oderda, G.
    Muyshont, L.
    Salame, A.
    Deyi, Y. Miendje
    Cadranel, S.
    Scaillon, M.
    [J]. HELICOBACTER, 2009, 14 (04) : 331 - 332
  • [43] Comparing Esomeprazole Based Versus Rabeprazole Based Triple Therapy for the Eradication of Helicobacter pylori in Japan
    Okimoto, Tadayoshi
    Mizukami, Kazuhiro
    Ogawa, Ryo
    Kodama, Masaaki
    Murakami, Kazunari
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S392 - S393
  • [44] Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border
    Cardenas, VM
    Graham, DY
    El-Zimaity, HM
    Opekun, AR
    Campos, A
    Chavez, A
    Guerrero, L
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (02) : 295 - 301
  • [45] Comparison of Lafutidine and Rabeprazole in 7-day Second-line Amoxicillin- and Metronidazole-Containing Triple Therapy for Helicobacter pylori: A Pilot Study
    Kudo, Takahiko
    Fujinami, Haruka
    Ando, Takayuki
    Nishikawa, Jun
    Ogawa, Kohei
    Hosokawa, Ayumu
    Orihara, Tadahiro
    Murakami, Jun
    Takahara, Terumi
    Sugiyama, Toshiro
    [J]. HELICOBACTER, 2012, 17 (04) : 277 - 281
  • [46] Efficacy of Rifabutin based triple therapy including PPI and high dose amoxicillin for third line rescue therapy of H-pylori
    Lee, Y.
    Moon, B.
    Jung, H.
    Ahn, S.
    Han, K.
    Cheon, J.
    Chung, J.
    Lee, S.
    [J]. HELICOBACTER, 2010, 15 (04) : 344 - 344
  • [47] Presence or absence of peptic ulcer disease does not affect H-pylori eradication rates with rabeprazole-based triple therapy
    Vakil, N
    Kovacs, T
    Ignatowitz, W
    Hahne, W
    Barth, J
    [J]. GUT, 2002, 51 : A93 - A93
  • [48] Rabeprazole 7-days vs. rabeprazole 10-days vs. rabeprazole 14 days triple therapy in the eradication of H pylori infection -: a randomized study.
    Karatapanis, S
    Georgopoulos, S
    Skorda, L
    Papantoniou, N
    Komnianides, K
    Lisgos, P
    Psellas, C
    Mentis, A
    Tsibidakis, H
    Kouvidou, H
    Lois, K
    Kipraios, D
    Artikis, V
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A428 - A428
  • [49] Antimicrobial resistance as a cause of failed H-pylori eradication:: Results of a US multicenter trial of rabeprazole-based triple therapy
    Vakil, N
    Jayanty, V
    Stanton, D
    Perdomo, C
    Hahne, W
    Barth, J
    [J]. GUT, 2002, 51 : A93 - A93
  • [50] A large-scale nationwide observational study of triple therapy using rabeprazole, amoxicillin and clarithromycin for H-pylori eradication in Japan
    Fujioka, T.
    Sugizaki, K.
    Sakata, Y.
    Arai, T.
    [J]. HELICOBACTER, 2010, 15 (04) : 339 - 339
12345